| (USD) | Jun 2025 | Y/Y change |
|---|---|---|
| Revenue | 1.25M | — |
| Operating expense | — | — |
| Net income | 0.00 | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, PRPH returned -99.3% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -95.1% |
| 1 year | -99.3% |
| 5 years | -100.0% |
| 10 years | -99.8% |
| All-time high | $190.00 (Sep 1997) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in PRPH would be worth today ›No. ProPhase Labs, Inc. has not paid a dividend in the past 12 months.
ProPhase Labs, Inc. is part of the Healthcare sector.
ProPhase Labs, Inc. has a market cap of 311.16K USD, based on the latest quote.
ProPhase Labs, Inc. is expected to report earnings around Aug 24, 2026. That date is an estimate and has not been confirmed by the company.